Pharmaceuticals · PSX stock comparison
Searle (SEARL) vs GlaxoSmithKline (GLAXO)
The Searle Company Limited and GlaxoSmithKline Pakistan Limited: compare valuation, dividends and financial performance side by side.
The Searle Company Limited
Rs 79.18
PSX snapshot · 18/11/2026, 18:41:00 PKT
GlaxoSmithKline Pakistan Limited
Rs 333.13
PSX snapshot · 18/11/2026, 18:41:00 PKT
Some annual figures are withheld pending current reporting-year verification.
| Metric | SEARL | GLAXO |
|---|---|---|
| Market & valuationPSX quotes; issuer filings and dated SCSTrade fundamentals | ||
| Share price | Rs 79.18 | Rs 333.13 |
| P/E (TTM) | 11.98× | 9.66× |
| Annual dividend yield | — | 5.10%FY 2025 |
| Annual dividend per share | — | Rs 17.00FY 2025 |
| Price / book (calculated) | 1.31×2027 Q1 | 3.08×2026 Q2 |
| Market cap | Rs 46.58B | Rs 106.09B |
| 1-year price change · excluding payouts | -24.70% | -14.20% |
| Profitability & financial healthIssuer filings / SCSTrade · period and source shown per figure | ||
| Book value per share | Rs 60.422027 Q1 | Rs 108.122026 Q2 |
| Return on equity (ROE) | — | 29.77%2025 Q4 |
| Return on assets (ROA) | — | 19.78%2025 Q4 |
| Gross profit margin | — | 37.00%2025 Q4 |
| Net profit margin | — | 15.21%2025 Q4 |
| Inventory turnover | — | 5.16×2025 Q4 |
| Current ratio | 1.87×2027 Q1 | 2.28×2026 Q2 |
| Quick ratio | — | 1.48×2025 Q4 |
Sources & reporting periods
Prices and trailing P/E: PSX DPS. Annual yield = full-year cash dividend divided by displayed PSX price. Annual dividends and financial ratios: reviewed issuer filings and SCSTrade. Financial year and dividend/share are shown for both stocks; unclear feed yields are excluded. Price/book uses reported book value. PSX 1-year price changes exclude payouts; they are not total returns. Reviewed issuer ratios use unconsolidated statements and labelled year-end denominators. Unverified borrowing ratios are omitted.
More pharmaceuticals comparisons
Pharmaceuticals
Pharmaceutical companies: compare profitability, returns and working capital.
